Research Rankings
Top Peptides Dashboard
Data-driven rankings of 147 peptides by research volume, human clinical evidence, evidence strength, and emerging research momentum.
147
Total Peptides
25
With Human Trials
8
High Evidence (FDA Approved+)
2
Emerging (2022+)
Most Studied. Top 25
Ranked by total indexed research references
12345678910111213141516171819202122232425
BPC-157
4 studies
TB-500
4 studies
Thymosin Beta-4
3 studies
Ipamorelin
3 studies
MK-677 (Ibutamoren)
3 studies
Semaglutide
3 studies
Tirzepatide
3 studies
GHK-Cu
3 studies
Semax
3 studies
Thymosin Alpha-1
3 studies
Apelin-13
3 studies
Davunetide (NAP/AL-108)
3 studies
PEG-MGF
2 studies
CJC-1295
2 studies
Tesamorelin
2 studies
Hexarelin
2 studies
AOD-9604
2 studies
Epitalon
2 studies
SS-31 (Elamipretide)
2 studies
Humanin
2 studies
MOTS-c
2 studies
Selank
2 studies
DSIP
2 studies
LL-37
2 studies
KPV
2 studies
Evidence Level Distribution
Level 4, Strong Clinical Evidence
85%
Level 3, Emerging Clinical Evidence
2819%
Level 2, Preclinical Evidence
2114%
Level 1, Early Research
9061%